News Formal

Biotech Stocks About to Make a Seasonal Move Higher? Here's How to Spot a Breakout

  • 📰 Investingcom
  • ⏱ Reading Time:
  • 18 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 53%

S&P 500 News

Ishares Biotechnology ETF

Stocks Analysis by Michele Schneider covering: S&P 500, iShares Biotechnology ETF. Read Michele Schneider's latest article on Investing.com

My weekend comments were, “IBB remains stuck in its weekly trading range. Remember, the longer the range sustains, the better the move out of it tends to be. IBB gets interesting over 150.”The July 6-month calendar range high and low .) this weekend, and the checkout person overheard me talking about buying toilet paper, or not buying it as they were out of Charmin.

What resonated with me was not the public hoarding mentality, but rather, the return of winter ills and chills.In the list of indicators, I draw your attention to Leadership. Now, a golden or bull cross looks like it’s ready to reemerge -with the price not too far from the moving averages for a relatively low risk.Scan QR code to install app

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 450. in CA

Canada Canada Latest News, Canada Canada Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Retail Stocks: Patience Now Could Mean Profits LaterStocks Analysis by Michele Schneider covering: S&P 500, SPDR® S&P Retail ETF. Read Michele Schneider's latest article on Investing.com
Source: Investingcom - 🏆 450. / 53 Read more »

Biotech stocks: Morgan Stanley previews the sector's third-quarter earnings seasonBiotech stocks: Morgan Stanley previews the sector's third-quarter earnings season
Source: Investingcom - 🏆 450. / 53 Read more »

These 9 biotech stocks have doubled this year and are set to double again, analysts sayThe bio tech stocks have on average risen by 188% this year and have a median upside potential of 150%.
Source: CNBC - 🏆 12. / 72 Read more »